Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Audeara.
RELATED STOCKHEAD STORIES
Health & Biotech
Primed for growth: Audeara increases sales channels by 20% by partnering with optometry giant Specsavers
News
Top 10 at 10: Which ASX stocks are flying on Friday?
Experts
ScoPo’s Powerplays: Health stocks bounce up and down as markets tumble
Tech
HealthKick Podcast: Audeara’s revenue up nearly 140pc YoY… and 50pc from the previous quarter
Health & Biotech
Morgans: This incredible Aussie medtech is trading at just ⅓ its real value
Health & Biotech
ScoPo’s Powerplays: All we want for Christmas is a market rally
Tech
Unicorns Podcast: Audeara’s smart headphones are music to the ears of investors
Health & Biotech
ScoPo’s Powerplays: Profit-taking on the cards for health stocks that have had good runs
Health & Biotech
ScoPo’s Powerplays: Recent price swings uncovered hidden gems and buying opportunities in healthcare
Health & Biotech
Dr Boreham’s Crucible: Who’s winning and losing in the life sciences IPO Olympiad?
Health & Biotech
ScoPo’s Powerplays: Solid earnings for health stocks all round, but price action stays with larger caps
Stockhead TV
Q-Wrapz: Oriel Morrison interviews Dr James Fielding, MD & CEO of Audeara Ltd (ASX:AUA)
News
Closing Bell: ASX 200 continues to soar as Japara set to agree to takeover deal
Health & Biotech
ScoPo’s Powerplays: Healthcare sector has bounced back as earnings season kicks off, expect to buy on the dips
Health & Biotech
ScoPo’s Powerplays: Buying opportunities in a volatile week
Tech
Morgans just tipped hearing tech play Audeara to nearly triple from its current price
Tech